BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2554363)

  • 21. Behavioral stimulation without alteration of beta and 5-HT receptors and adenylate cyclase activity in rat brain after chronic sertraline administration.
    Tadokoro C; Kiuchi Y; Yamazaki Y; Nara K; Oguchi K; Kamijima K
    Psychopharmacology (Berl); 1997 Mar; 130(2):124-30. PubMed ID: 9106909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single or repeated administrations of SCH 23390 fail to affect serotonergic neurotransmission.
    Gandolfi O; Roncada P; Dall'Olio R
    Neurosci Lett; 1988 Oct; 92(2):192-6. PubMed ID: 2460808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of some tricyclic and nontricyclic antidepressants on [3H]imipramine binding and serotonin uptake in rat cerebral cortex after prolonged treatment.
    Brunello N; Riva M; Volterra A; Racagni G
    Fundam Clin Pharmacol; 1987; 1(5):327-33. PubMed ID: 3443425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the regulatory adaptation of the 5HT recognition sites labelled by 3H-mianserin or 3H-ketanserin.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Neuropharmacology; 1983 Jan; 22(1):123-6. PubMed ID: 6843781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain.
    Maj J; Dziedzicka-Wasylewska M; Rogoz R; Rogóz Z; Skuza G
    Eur J Pharmacol; 1996 May; 304(1-3):49-54. PubMed ID: 8813583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites.
    Barbaccia ML; Gandolfi O; Chuang DM; Costa E
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5134-8. PubMed ID: 6308674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased low-affinity 3H-spiroperidol binding to rat cortical membranes after chronic antidepressant treatments.
    Antkiewicz-Michaluk L; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(3):317-23. PubMed ID: 4070080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on beta-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortex.
    Hall H; Ross SB; Sällemark M
    J Neural Transm; 1984; 59(1):9-23. PubMed ID: 6325593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1989; 41(4):313-9. PubMed ID: 2561380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of sodium-dependent [3H]imipramine binding in rat brain by serotonin and serotonin uptake inhibitors.
    Hrdina PD
    Eur J Pharmacol; 1988 Mar; 148(2):279-82. PubMed ID: 3259932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p-chlorophenylalanine-reversible reduction of sigma binding sites by chronic imipramine treatment in rat brain.
    Shirayama Y; Nishikawa T; Umino A; Takahashi K
    Eur J Pharmacol; 1993 Jun; 237(1):117-26. PubMed ID: 8359206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant binding: implications for the mode of action and the biology of depression.
    Hrdina PD
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):457-62. PubMed ID: 6320297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic effects of imipramine and lithium on postsynaptic 5-HT1A and 5-HT1B sites and on presynaptic 5-HT3 sites in rat brain.
    Mizuta T; Segawa T
    Jpn J Pharmacol; 1988 Jun; 47(2):107-13. PubMed ID: 3199589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of new antidepressants.
    Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(1):97-108. PubMed ID: 6145191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions.
    Racagni G; Mocchetti I; Calderini G; Battistella A; Brunello N
    Neuropharmacology; 1983 Mar; 22(3 Spec No):415-24. PubMed ID: 6304559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of serotonin in the regulation of beta-adrenoceptors by antidepressants.
    Asakura M; Tsukamoto T; Kubota H; Imafuku J; Ino M; Nishizaki J; Sato A; Shinbo K; Hasegawa K
    Eur J Pharmacol; 1987 Sep; 141(1):95-100. PubMed ID: 2822448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants.
    Hrdina PD
    Eur J Pharmacol; 1987 Jun; 138(2):159-68. PubMed ID: 3040430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of mianserin, a new antidepressant, on the in vitro and in vivo uptake of monoamines.
    Goodlet I; Mireylees SE; Sugrue MF
    Br J Pharmacol; 1977 Oct; 61(2):307-13. PubMed ID: 922259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.